Legal Representation
Attorney
Jeffrey H. Handelsman
USPTO Deadlines
Next Deadline
1085 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221213)
Due Date
December 13, 2028
Grace Period Ends
June 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 13, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 13, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 8, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 7, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 25, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Oct 17, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 17, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 20, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 19, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 13, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 19, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 13, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 16, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 14, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 14, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 14, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 15, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 13, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 13, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 13, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 16, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 14, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 14, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 14, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 17, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 15, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 15, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 15, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 15, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 20, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 20, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 31, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 24, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 15, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 8, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 8, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 8, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 8, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 8, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 14, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 14, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 14, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 14, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 22, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 8, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and medicated preparations for use in neurology; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of female sexual dysfunction; all of the aforesaid goods not for use as a product name of a pharmaceutical product
First Use Anywhere:
Nov 6, 2017
First Use in Commerce:
Nov 6, 2017
Additional Information
Translation
The wording "SEBELA" has no meaning in a foreign language.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"